Effects Of Otago Exercise Versus Multisensory Integration Training On Balance And Gait In Elderly With Diabetes

Sponsor
Cairo University
Study ID
NCT07776535
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Balance
  • Diabetes Mellitus
  • Gait

Eligibility Criteria

Sex
ALL
Age
65 Years - 75 Years
Healthy Volunteers
Not accepted

Interventions

  • Otago exercise — OTHER
    Exercise program consisted of ( flexibilty - strengthening - balance ) exercise for elderly. Time of each session (50:60 min). For 3d/w for 8weeks.
  • Multisensory integration training — OTHER
    Multisensory integration training is a group of balance exercise depend on facilitating different sensory systems (visual-vestibular-propioception) Time for each session (50 min). For 3d/w for 8weeks.
  • conventional treatment for neuropathy — OTHER
    conventional treatment for improving balance and gait problem associated with DPN For 3d/w for 8weeks

Study Details

The goal of this clinical trial is to compare the effect of the Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus. The main question it aims to answer is: • Is there a significant difference between the effect of Otago exercise and Multisensory integration training on balance and gait in the elderly with type 2 diabetes mellitus? Researchers will compare Otago exercise to Multisensory integration training to know which one has the greatest benefit on balance \&gait in the elderly with type2 diabetes. Participants will be divided into 3 groups; each group takes a certain training program for 8 weeks: * First group: Otago exercise group plus conventional treatment for neuropathy. * Second group: Multisensory integration training group plus conventional treatment for neuropathy. * Third group: control group takes only conventional treatment for neuropathy.

Key Dates

First listed
Aug 20, 2026
Start date
Oct 31, 2026
Status verified
Aug 2026
Primary completion
Oct 31, 2027
Completion
Nov 30, 2027

Study Design

Enrollment
90 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Otago exercise group
    Otago exercise plus conventional treatment for neuropathy. for 3d/w for 8weeks.
  • Active Comparator: Multisensory integration training group
    Multisensory integration training group with conventional treatment for neuropathy. for 3d/w for 8 weeks.
  • Active Comparator: control group
    Only conventional treatment for neuropathy For 3d/w for 8 weeks.

Primary Outcome Measure

Balance: ( Time up & go test )dual task [ Time Frame: From enrollment to the end of treatment at 8 weeks ]

Central Contacts

Related Studies